Differential regulation of cellular pathways in response to IR between apoptosis-sensitive and -resistant ALL tumors by GSEA analysis
| Pathway name . | No. genes in the pathway . | NOM P . | FDR q . |
|---|---|---|---|
| PDGF | 20 | 0 | .005 |
| PTEN | 16 | 0 | .007 |
| Insulin | 18 | 0 | .007 |
| EGF | 20 | 0 | .006 |
| B-cell receptor complexes | 16 | .002 | .02 |
| IGF1 | 17 | 0 | .027 |
| Oxidative phosphorylation | 29 | .01 | .052 |
| CREB | 19 | .002 | .064 |
| mRNA processing | 18 | 0 | .092 |
| Inositol phosphate metabolism | 15 | .008 | .095 |
| S1P signaling | 16 | .004 | .088 |
| Insulin receptor pathway in cardiac myocytes | 43 | .008 | .134 |
| mRNA splicing | 20 | .017 | .162 |
| TPO pathway | 17 | .031 | .215 |
| Insulin signaling | 19 | .014 | .201 |
| IL6 pathway | 18 | .051 | .238 |
| G13 signaling pathway | 17 | .027 | .226 |
| IL2 | 17 | .017 | .243 |
| TRKA receptor | 15 | .036 | .247 |
| Pathway name . | No. genes in the pathway . | NOM P . | FDR q . |
|---|---|---|---|
| PDGF | 20 | 0 | .005 |
| PTEN | 16 | 0 | .007 |
| Insulin | 18 | 0 | .007 |
| EGF | 20 | 0 | .006 |
| B-cell receptor complexes | 16 | .002 | .02 |
| IGF1 | 17 | 0 | .027 |
| Oxidative phosphorylation | 29 | .01 | .052 |
| CREB | 19 | .002 | .064 |
| mRNA processing | 18 | 0 | .092 |
| Inositol phosphate metabolism | 15 | .008 | .095 |
| S1P signaling | 16 | .004 | .088 |
| Insulin receptor pathway in cardiac myocytes | 43 | .008 | .134 |
| mRNA splicing | 20 | .017 | .162 |
| TPO pathway | 17 | .031 | .215 |
| Insulin signaling | 19 | .014 | .201 |
| IL6 pathway | 18 | .051 | .238 |
| G13 signaling pathway | 17 | .027 | .226 |
| IL2 | 17 | .017 | .243 |
| TRKA receptor | 15 | .036 | .247 |
NOM P indicates nominal probability.